| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.005 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.006 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.006 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.094 | 0.006 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.006 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |